Search results
287 Results for 'brain'
Technologies 21
-
Engineered Brain Organoids
The ability to derive and manipulate pluripotent stem cells has opened up new avenues for modeling biological systems in both healthy and diseased conditions. In order to more fully recapitulate the tissue microenvironment with its cell-cell, cell-extracellular matrix, and cell-niche interactions, it is essential to transition stem-cell culturing from monolayers to 3D structures. Self-organization of... -
Cellular “Backpacks” to Fight Cancer, Autoimmune Disorders, and More
Macrophages are very malleable immune cells, but that also means that they can be influenced by cancerous tumors and inflammatory processes. Our cellular "backpacks" stick to macrophages and can deliver molecules that keep them in their desired state for cell therapy and more. -
Soft hydrogel electrodes for better, safer implants
Soft, conductive hydrogels match the physical properties of the human brain, enabling the creation of electrodes and implantable devices that can improve brain-machine interfaces while reducing the risk of injury. -
CogniXense for Rare Disease Drug Discovery
Unravel Biosciences has licensed a Wyss drug discovery platform technology to identify and create drugs to treat complex central nervous system disorders, starting with Rett syndrome. -
CircaVent: A Drug Discovery Platform for Mental Health Conditions
CircaVent is a novel drug discovery platform that combines predictive algorithms, high-throughput preclinical models, and human organoids to identify and test drugs that could treat mental health conditions like bipolar disorder. -
CogniXense: A Platform for Rapid Drug Repurposing
CogniXense is a target-agnostic drug discovery platform that enables the repurposing of drugs for rare genetic diseases in record time. By combining human data-based computational drug prediction with on-demand animal model development, we can mimic the diversity of symptoms of patient populations and begin drug screening on new diseases within a month.
Collaborations 5
-
Brain Targeted Therapeutic Collaboration
Combine our shuttles with your drugs to create new brain targeted therapeutics for patients. -
Brain Shuttle Research Sponsorship & Licensing
Enabling brain-targeted drug development through non-exclusive licensing and pre-competitive research sponsorship. -
Bridging the Funding Gap for Brain Therapeutics
A unique opportunity to help develop a new generation of brain targeted drugs -
Wyss Brain Targeting Program
Advancing brain delivery approaches that enable more safe and effective brain-targeted therapeutics. -
Nucleic Acid Delivery Consortium
An academic-industry consortium focused on the challenge of delivering nucleic acid-based therapies to specific target organs, tissues, and cells.
People 8
-
Scientist I
Ana Raquel P. Santa Maria, Ph.D. -
Scientist II - Neuroscience
Yifei Lu, Ph.D. -
Principal Scientist
Liqun Wang, Ph.D. -
Senior Director, Translational R&D
James Gorman, M.D., Ph.D. -
Research Assistant III - Biosensors and Microfluidics
Alden Tennison -
Research Assistant II – Brain Organoid Engineering
Matthew Woodworth
News 176
Pages 2
Multimedia 29
-
Audio/PodcastBrain Shuttles: A New Path Into the Brain with James Gorman of the Wyss InstituteThe host of Business Trip, Matias Serebrinsky, interviews Wyss Senior Director of Translational R&D James (Jim) Gorman, M.D., Ph.D. Jim is a Principal Investigator of the Wyss Institute Brain Targeting Program (BTP). He leads a team developing new approaches to transport drugs through the blood-brain barrier (BBB) into the central nervous system. In this episode,... -
Video/AnimationHow can we better treat brain diseases?The Brain Targeting Program at the Wyss Institute is a pre-competitive, multi-partner industry collaboration that aims to identify novel transport targets and shuttle compounds to enable more effective delivery of drugs to the brain. Credit: Wyss Institute at Harvard University -
Audio/PodcastCan we grow a conscious brain? – CrowdSciencePhilosophers have long pondered the concept of a brain in a jar, hooked up to a simulated world. Though this has largely remained a thought experiment, CrowdScience listener JP wants to know if it might become reality in the not-too-distant future, with advances in stem cell research. In the two decades since stem cell research... -
Video/AnimationWyss Institute Brain Targeting ProgramThis animation explains how Wyss Institute researchers and their industry partners aim to identify novel transport targets and shuttle compounds to enable more effective delivery of drugs to the brain. Credit: Wyss Institute at Harvard University. -
Video/AnimationEliminating brain cancer at its source | Natalie Artzi | TEDxMITGlioblastoma is a lethal, aggressive brain cancer with a dismal median overall survival rate of 15 months, a number that has remained unchanged for decades. Treatment for this devastating disease involves surgical resection followed by chemotherapy and radiation therapy; however, tumor recurrence is inevitable as it is impossible to eliminate all tumor cells with current... -
Video/AnimationSoft Robotic Gripper for Jellyfish 2.0Scientists from the Wyss Institute at Harvard University and CUNY have created ultra-soft robotic grippers that resemble fettuccini noodles to safely catch and release delicate underwater creatures like jellyfish without harm. Credit: Wyss Institute at Harvard University
Publications 36
-
December 24, 2025
Alzheimer's & Dementia
Transport target expression, a biomarker of brain shuttle fusion drug uptake, shows minimal influence of brain region, disease state, gender, and age, yet reveals significant individual variation
-
May 14, 2026
Philosophical Transactions of the Royal Society A
Brains and where else? Mapping theories of consciousness to unconventional embodiments
-
November 4, 2023
iScience
Information integration during bioelectric regulation of morphogenesis of the embryonic frog brain
-
April 16, 2025
Bioengineering & Translational Medicine
Cell therapies against brain tumors: Clinical development and emerging prospects
-
January 16, 2026
iScience
A human blood-brain barrier model reveals pericytes as critical regulators of viral neuroinvasion
-
November 5, 2025
Nature Biotechnology
A nonsurgical brain implant enabled through a cell-electronics hybrid for focal neuromodulation
Jobs 2
-
Scientist II
Research and Technology DevelopmentWe are looking for a talented scientist to lead the development and characterization of our antibody brain shuttle compounds and to optimize our shuttles for specific payloads in neurodegenerative diseases. Reporting to the Principal Scientist, you will work closely with our team, Brain Targeting Program (BTP), using both in vitro cellular systems and in vivo humanized mouse models. You will determine brain PK/PD profiles of our shuttle compounds, their biophysical properties, and assess therapeutic applications. The mission of the Wyss BTP is to develop a robust modular brain delivery platform that is able to deliver large-molecule therapeutics for diverse brain diseases. We aim to help expand the pipeline of CNS drugs by making our platform broadly available to companies, academics and non-profit organizations. [004160SR]
-
Visiting Student & Internship Opportunities
Academic PositionThe Wyss Institute does not currently offer a formal internship program. If you are interested in working at the Wyss, please email your CV and research background to Laura Falloon, Academic Affairs Manager at laura.falloon@wyss.harvard.edu, for consideration for current or future opportunities. Please also indicate which Wyss teams best align with your background and research interests.
You can explore our Advanced Technology Team member profiles to learn more about what Wyss scientists are working on and which teams may be the best fit for your interests.
My time at the Wyss was an opportunity to work in a collaborative academic environment that helped me confirm I wanted to pursue a research career in the future!
Daniel Aluko, Former Visiting Undergraduate Research Fellow in the Ingber Lab My research stay as a Visiting Graduate Researcher in the Brain Targeting Program at the Wyss Institute provided me with excellent preparation for my current PhD, both in terms of theoretical knowledge and advanced methodologies.
Marvin Porsiel, Former Visiting Graduate Student in the Brain Targeting Program 
1/7 Wyss visiting students are invited to attend the annual Wyss Retreat. Credit: Wyss Institute at Harvard University 
2/7 Visiting students and interns attend Wyss symposia and events with their team members, such as the Wyss Brain Targeting Program's annual meeting with external partners. Credit: Wyss Institute at Harvard University 
3/7 Visiting students and interns participate in Institute-wide social gatherings such as our annual Halloween costume party. Credit: Wyss Institute at Harvard University 
4/7 Visiting students and interns are members of large and small project teams. The CircaVent team is pictured here at the 2023 Wyss Retreat. Credit: Wyss Institute at Harvard University 
5/7 Wyss Institute interns gain hands-on experience working with multidisciplinary teams in state-of-the-art lab facilities. Credit: Wyss Institute at Harvard University 
6/7 Visiting students and interns attend Wyss Meet and Greets and other social events. Credit: Wyss Institute at Harvard University 
7/7 Visiting students and interns attend Wyss Meet and Greets and other social events. Credit: Wyss Institute at Harvard University
Events 8
-
Nov 1, 2023, 4:00pm - 5:30pmWyss Event

- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Hosted by Wyss Core Faculty David R. Walt, PhD, Diagnostics Grand Rounds brings clinicians with unmet needs to the Wyss Institute. The goal of these sessions is to inform technology developers about important clinical problems that can help them direct their technology development efforts. Presenters are asked to identify diagnostic needs that will have an... Free and open to public -
Sep 4, 2018, 4:00pm - 5:00pmWyss Event

- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Dr. Camarillo’s laboratory combines mechanics, medicine, and technology to solve clinical problems with medical devices. In this talk, he will describe his lab’s work on two clinically relevant problems of: measuring dynamic movements in the lung using the camera image of a bronchoscope, and measuring dynamic impact to the head using an instrumented mouthguard. The... -
Jan 26, 2017, 4:00pm - 5:30pmLecture

- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Harvard Medical School’s Department of Neurobiology will host The Alice and Joseph Brooks International Lecture on the Neurosciences, on Thursday, January 26, 2017, at 4:00pm. 2017 Keynote Speaker: Edvard Moser, Ph.D. The Hippocampal-Entorhinal Space Circuit: Development and Function Free and open to public
Collaboration
Reimagine the World